Gyf. Ho et al., RISK OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN WOMEN WITH HUMAN IMMUNODEFICIENCY VIRUS-INDUCED IMMUNOSUPPRESSION, International journal of cancer, 56(6), 1994, pp. 788-792
This study examined the risk factors for genital human papillomavirus
(HPV) infection, including HIV-related immunosuppression as well as de
mographic and behavioral factors. Subjects were 207 women with known H
IV serologic status, the majority of whom were intravenous drug users
recruited from a methadone treatment program in the Bronx, New York. A
structured questionnaire interview, cervico-vaginal lavage, and CD4 c
ell measurements were obtained. HPV genomes in the cervico-vaginal cel
ls were detected by Southern-blot hybridization. HPV prevalence was 23
% among HIV seronegatives, 45% among HIV seropositives with CD4 percen
t >20 and 61% among HIV seropositives with CD4 percent less than or eq
ual to 20. Multivariate analysis identified the following independent
risk factors that were significantly associated with HPV positivity: H
IV-related immunosuppression, <35 years of age, and never used oral co
ntraceptive pills. HIV-related immunosuppression was also associated w
ith a stronger Southern-blot signal strength. HIV infection, however,
did not increase the susceptibility to HPV infection with the oncogeni
c types (16, 18, 31, 33 and 35). Women with HIV infection or immunosup
pression had a higher prevalence of HPV infection with the oncogenic t
ypes, but they also had an increased prevalence of infection with othe
r HPV types as compared to the HIV-seronegative women. The results sug
gest that HIV-related immunosuppression increases the risk of genital
HPV infection and has an effect on HPV replication. (C) 1994 Wiley-Lis
s, Inc.